Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 2
2022 2
2023 3
2024 8
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation.
Hangiu O, Navarro R, Frago S, Rubio-Pérez L, Tapia-Galisteo A, Díez-Alonso L, Gómez-Rosel M, Silva-Pilipich N, Vanrell L, Smerdou C, Howard KA, Sanz L, Álvarez-Vallina L, Compte M. Hangiu O, et al. Among authors: silva pilipich n. Front Immunol. 2025 Jan 6;15:1494206. doi: 10.3389/fimmu.2024.1494206. eCollection 2024. Front Immunol. 2025. PMID: 39835115 Free PMC article.
A new generation of vaccines based on alphavirus self-amplifying RNA.
Ballesteros-Briones MC, Silva-Pilipich N, Herrador-Cañete G, Vanrell L, Smerdou C. Ballesteros-Briones MC, et al. Among authors: silva pilipich n. Curr Opin Virol. 2020 Oct;44:145-153. doi: 10.1016/j.coviro.2020.08.003. Epub 2020 Sep 6. Curr Opin Virol. 2020. PMID: 32898764 Free PMC article. Review.
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.
Blanco E, Silva-Pilipich N, Bocanegra A, Chocarro L, Procopio A, Ausín K, Fernandez-Irigoyen J, Fernández L, Razquin N, Igea A, Garnica M, Echaide M, Arasanz H, Vera R, Escors D, Smerdou C, Kochan G. Blanco E, et al. Among authors: silva pilipich n. Br J Cancer. 2024 Mar;130(5):869-879. doi: 10.1038/s41416-023-02561-y. Epub 2024 Jan 9. Br J Cancer. 2024. PMID: 38195888 Free PMC article.
DNA electroporation in a vacuum: A "shocking" innovation for vaccines.
Silva-Pilipich N, Lasarte-Cía A, Lasarte JJ, Smerdou C. Silva-Pilipich N, et al. Mol Ther Nucleic Acids. 2024 Jan 5;35(1):102110. doi: 10.1016/j.omtn.2023.102110. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38274365 Free PMC article. No abstract available.
Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses.
Silva-Pilipich N, Blanco E, Lozano T, Martisova E, Igea A, Herrador-Cañete G, Ballesteros-Briones MC, Gorraiz M, Sarrión P, González-Sapienza G, Lasarte JJ, Vanrell L, Smerdou C. Silva-Pilipich N, et al. Cancer Lett. 2023 May 1;561:216139. doi: 10.1016/j.canlet.2023.216139. Epub 2023 Mar 29. Cancer Lett. 2023. PMID: 37001752 Free article.
19 results